Sign in

CIK 0001348362

  • Non-accelerated filer
  • Smaller reporting company

Lexaria Bioscience Corp.

Sign in to watch
Ticker
LEXX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Aug 31
Incorporated
NV
Entity type
Operating
EIN
202000871
Phone
+1 250-765-6424
Business address
100 - 740 MCCURDY ROAD, KELOWNA, British Columbia, Canada, V1X 2P7
Former names
Lexaria Corp., LEXARIA CORP.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-05-15 Bhullar Baljinder Director Grant or award · Stock Options +11,000 11,000
2015-12-16 Bhullar Baljinder CFO Grant or award +14,125 155,375
2015-09-21 Bhullar Baljinder CFO Other disposition · Warrants −100,000 $0.25 $25K 0
2014-12-23 Bhullar Baljinder CFO Grant or award · Stock Options +50,000 $0.10 $5K 852,500
2014-12-23 Bhullar Baljinder CFO Purchase · Stock Options +500,000 $0.11 $55K 1,075,000
2014-03-21 Bhullar Baljinder CFO Purchase +100,000 $0.12 $12K 100,000
2014-03-21 Bhullar Baljinder CFO Purchase · Warrants +100,000 $0.25 $25K 100,000
2013-06-18 Bhullar Baljinder CFO Grant or award · Stock Options +17,500 $0.09 $2K 302,500
2013-06-18 Bhullar Baljinder CFO Purchase · Stock Options +175,000 $0.10 $18K 175,000
2011-07-11 Bhullar Baljinder CFO Grant or award · Stock Options +10,000 $0.32 $3K 110,000
2010-01-01 Bhullar Baljinder CFO Other disposition · Stock Options −300,000 $0.20 $60K 0

Page 1 of 1 · 11 trades